Matrixyl (Palmitoyl Pentapeptide)

Matrixyl (Palmitoyl Pentapeptide-4, KTTKS) is a synthetic lipopeptide widely used in cosmetic skincare products for its collagen-stimulating properties. The pentapeptide sequence KTTKS is a fragment of type I collagen's procollagen propeptide, which signals fibroblasts to produce new collagen as part of wound healing. The palmitoyl (palmitic acid) modification enhances skin penetration and cellular uptake. Research demonstrates Matrixyl stimulates collagen I, collagen IV, fibronectin, and glycosaminoglycan synthesis in dermal fibroblasts. Clinical studies show improvements in skin texture, wrinkle depth, skin firmness, and overall skin appearance with regular topical application. The peptide is considered safe for cosmetic use with no significant adverse effects reported. Matrixyl 3000, a combination of Palmitoyl Tripeptide-1 and Palmitoyl Tetrapeptide-7, provides additional anti-inflammatory benefits. Unlike more invasive anti-aging treatments, signal peptides like Matrixyl work by mimicking natural skin repair processes. The peptide has become a cornerstone ingredient in anti-aging skincare formulations.

Clinical evidence is mostly from small or manufacturer-affiliated cosmetic studies measuring wrinkle metrics; there are no large independent trials. Matrixyl is a cosmetic ingredient, not a drug, and claims are limited to appearance improvement.

Matrixyl is a lipophilic palmitoylated pentapeptide (pal-KTTKS) designed for topical application to improve dermal penetration. It is a cosmetic active ingredient, not a systemic drug, so no systemic pharmacokinetics apply to typical topical use.